Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00108_DB00291> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00108_DB00291 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00108_DB00291 label "DDI between Natalizumab and Chlorambucil - Immunosuppressants such as chlorambucil may enhance the adverse/toxic effect of natalizumab. Specifically, the risk of concurrent infection may be increased. Patients receiving natalizumab should not use concurrent immunosuppressants. [drugbank_resource:DB00108_DB00291]" assertion.
- drugbank_resource:DB00108_DB00291 identifier "drugbank_resource:DB00108_DB00291" assertion.
- drugbank_resource:DB00108_DB00291 title "DDI between Natalizumab and Chlorambucil - Immunosuppressants such as chlorambucil may enhance the adverse/toxic effect of natalizumab. Specifically, the risk of concurrent infection may be increased. Patients receiving natalizumab should not use concurrent immunosuppressants." assertion.